Back to today’s briefing

Story perspectives

90% Testing Rate for Gynecological Cancers via Genetic Testing

4/24/2025

42 9

Summary

Story summary

A groundbreaking study in the U.S. reveals that point-of-care genetic testing at the time of diagnosis skyrockets testing rates for gynecological cancers to an impressive 90%. Alarmingly, over 20% of those tested carried disease-causing mutations, paving the way for timely interventions and treatment options, echoing the Society of Gynecologic Oncology's call for universal testing.

1 of 1

Story summary

A groundbreaking study in the U.S. reveals that point-of-care genetic testing at the time of diagnosis skyrockets testing rates for gynecological cancers to an impressive 90%. Alarmingly, over 20% of those tested carried disease-causing mutations, paving the way for timely interventions and treatment options, echoing the Society of Gynecologic Oncology's call for universal testing.